What is Tianjin Ringpu Bio-Technology Co.,Ltd.'s (300119.SZ) StockRank?

MoatMap's StockRank for Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) is 55/100, with a Hold signal. This is a composite score combining Quality (54), Value (50), and Momentum (41) factor ranks across MoatMap's 19,000+ stock universe.

Does Tianjin Ringpu Bio-Technology Co.,Ltd. have an economic moat?

Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Tianjin Ringpu Bio-Technology Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) is Hold, based on a StockRank of 55/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Tianjin Ringpu Bio-Technology Co.,Ltd. in?

Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300119.SZ

HOLDREMOVE

Tianjin Ringpu Bio-Technology Co.,Ltd. · Healthcare · China · $1.1B · Avg Vol: $8M/d

StockRank

P/E (TTM)

18.5x

ROE

8.3%

D/E

0.3x

Dividend %

2.5%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Tianjin Ringpu Bio-Technology is a domestic Chinese animal healthcare provider. It lacks a global scale runway, has limited pricing power, and does not align with our high-conviction global macro themes.

COMPANY DESCRIPTION

Tianjin Ringpu Bio-Technology Co., Ltd. researches, develops, and manufactures veterinary biological products, pharmaceuticals, and animal health additives. The company is a market leader in China's animal health sector, offering a comprehensive product portfolio for poultry, livestock, and companion animals. Its competitive advantage is sustained by state-of-the-art biosafety laboratories, proprietary vaccine strains, and a highly technical sales support network.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	308M	400M	454M	502M	17.7%
EPS	0.11	0.14	0.10	0.13	5.6%
Shares	468M	466M	466M	465M	-0.7%
Debt	130M	133M	204M	216M	18.5%
Equity	624M	675M	661M	695M	3.7%
Op CF	58M	61M	109M	44M	-8.6%
Inv CF	-184M	-45M	-67M	15M	—
Fin CF	-7M	-25M	-20M	-37M	—

PRICE (1M)-10.5%

SMA 50SMA 200

$2.31

RSI (14)

46.9

52W High

$3.84

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

8.8%69.7

ROE

8.3%67.0

GP/Assets

18.2%42.4

Op. Margin

15.0%74.8

FCF/Assets

-4.1%37.5

Piotroski

—55.8

Int. Cover

14.4x69.6

D/E Ratio

0.29x43.8

Current Ratio

1.80x33.0

Value

P/E (TTM)

18.5x61.5

EV/EBITDA

12.5x34.5

P/FCF

—N/A

P/B

1.5x66.2

P/S

2.2x66.1

Div Yield

2.5%59.4

Momentum

52W High %

60%41.0

RS 6M

-25%48.4

SMA 50/200

0.89x31.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+40%49.2

Q Growth

-7%34.5

FUNDAMENTALS

Market Cap

$1.1B

P/E (Forward)

13.2x

Gross Margin

40.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300119.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.(you)	$1.1B	55	HOLD
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.	$984M	54	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
301393.SZ	Suzhou Highfine Biotech Co., Ltd.	$896M	55	HOLD
2186.HK	Luye Pharma Group Ltd.	$1.1B	61	HOLD
300725.SZ	PharmaBlock Sciences (Nanjing), Inc.	$1.2B	60	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
601089.SS	Beijing Foyou Pharma CO.,LTD	$1.3B	61	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
600557.SS	Jiangsu Kanion Pharmaceutical Co.,Ltd.	$1.1B	65	HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) — Stock Score Summary

Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) has a MoatMap StockRank of 55/100 based on Quality (54/100), Value (50/100), and Momentum (41/100) factor scores. The current signal is HOLD. Tianjin Ringpu Bio-Technology is a domestic Chinese animal healthcare provider. It lacks a global scale runway, has limited pricing power, and does not align with our high-conviction global macro themes.

Key Financial Metrics

Price	$2.31
Market Cap	$1.1B
P/E (TTM)	18.45
P/E (Forward)	13.15
Price/Book	1.50
Return on Equity	8.3%
Return on Invested Capital	8.8%
Debt/Equity	28.97
Gross Margin	40.7%
Operating Margin	15.0%
Revenue Growth	0.5%
Dividend Yield	2.5%
Free Cash Flow	$-7M

Tianjin Ringpu Bio-Technology Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Tianjin Ringpu Bio-Technology Co.,Ltd.’s (300119.SZ) StockRank?: MoatMap’s StockRank for Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) is 55/100, with a Hold signal. It is a composite of Quality (54), Value (50), and Momentum (41) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tianjin Ringpu Bio-Technology Co.,Ltd. have an economic moat?: Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tianjin Ringpu Bio-Technology Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) is Hold, based on a StockRank of 55/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tianjin Ringpu Bio-Technology Co.,Ltd. in?: Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).